In line with these observations, Yan et al. noted that in HCC, the dopamine-generating enzyme dopa decarboxylase was upregulated, while MAO-A was downregulated, leading to a dopamine imbalance that promoted HCC proliferation and metastasis via the DRD1 dopamine receptor [141]. Here, DRD1 is linked to hepatocellular carcinoma.